MedTrace Logo

Phase I Study: Stop Smoking Therapy for Ontario Patients (STOP)

NCT00356993 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6009

Last updated 2021-11-30

Study results available
· View outcomes & findings →

Summary

20% of Ontarians smoke. There was a decline in smoking prevalence from 1995 but it has remained unchanged since 2002. This rate of smoking cessation has not kept up with the rest of Canada. A new strategy is necessary to increase the number of smokers making quit attempts and to increase the odds of quitting long term.The goal of this study is to evaluate the methods and effectiveness of providing nicotine replacement (NRT) to Ontario smokers. The study will develop an evidence-based protocol for providing NRT, provide faculty development on combining pharmacotherapy with behavioural interventions and will provide an evaluation framework to inform future coverage models.

Conditions

  • Smoking

Interventions

DRUG

Nicotine Replacement Therapy

transdermal nicotine patch, nicotine gum, nicotine inhaler, nicotine lozenge

BEHAVIORAL

behavioural intervention

Smoking cessation counselling, relapse prevention strategies

Sponsors & Collaborators

  • Ontario Ministry of Health and Long Term Care

    collaborator OTHER_GOV

  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • Peter Selby, MD, MHSc · Centre for Addiction and Mental Health

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2018-03-30
Completion
2018-03-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00356993 on ClinicalTrials.gov